Factory Price High Purity 99.0% Pasireotide CAS No.: 96091-73-9

Model NO.
Pasireotide
Classification
Peptide
Function
Promote Digestion and Appetite
Appearance
Powder
Transport Package
10vilas/Kit
Specification
2mg, 5mg, 10mg
Trademark
RunYan
Origin
Zhongguo Hangzhou
Production Capacity
10000kg
Reference Price
$ 4.50 - 61.20
Contact Us

Product Description

Factory Price High Purity 99.0% Pasireotide raw peptide powder CAS NO.:96091-73-9 Research Chemical
Appearance White powder
Purity (HPLC) ≥95.0%

Acetate content 5.0%~12.0%

Moisture content≤8.0%

Peptide content ≥ 80.0%

Packaging and Shipping:

Low temperature, vacuum packaging, accurate to milligrams upon request.

Product Description:

Pasireotide is a somatostatin analog with a cyclic hexapeptide structure. Pasireotide, as the main component of the drug, is suitable for the treatment of adult patients with Cushing's disease who have not undergone pituitary surgery or have not been cured by surgery. Compared with octreotide, pasiiretide has a longer half-life, can bind to more receptors, inhibit pancreatic secretion, inhibit the activity of intestinal proteolytic enzymes, and reduce postoperative complications of pancreas through these mechanisms.

Storage method: Freeze-dry at -20°C and store in the dark

Remarks: For research only, not for human use

Factory Price High Purity 99.0% Pasireotide CAS No.: 96091-73-9 Factory Price High Purity 99.0% Pasireotide CAS No.: 96091-73-9 Factory Price High Purity 99.0% Pasireotide CAS No.: 96091-73-9 Factory Price High Purity 99.0% Pasireotide CAS No.: 96091-73-9 Factory Price High Purity 99.0% Pasireotide CAS No.: 96091-73-9
Factory Price High Purity 99.0% Pasireotide raw peptide powder CAS NO.:96091-73-9 Research Chemical
Appearance White powder
Purity (HPLC) ≥95.0%

Acetate content 5.0%~12.0%

Moisture content≤8.0%

Peptide content ≥ 80.0%

Packaging and Shipping:

Low temperature, vacuum packaging, accurate to milligrams upon request.

Product Description:

Pasireotide is a somatostatin analog with a cyclic hexapeptide structure. Pasireotide, as the main component of the drug, is suitable for the treatment of adult patients with Cushing's disease who have not undergone pituitary surgery or have not been cured by surgery. Compared with octreotide, pasiiretide has a longer half-life, can bind to more receptors, inhibit pancreatic secretion, inhibit the activity of intestinal proteolytic enzymes, and reduce postoperative complications of pancreas through these mechanisms.

Storage method: Freeze-dry at -20°C and store in the dark

Remarks: For research only, not for human use
 




 

 

Biochemical

LEGALIS.IT, 2023